Memantine vs Upadacitinib
Memantine vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Memantine and Upadacitinib.
Mechanism of Action
Memantine: Non-competitive NMDA receptor antagonist.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Memantine — 60-80 hours; Upadacitinib — 9-14 hours.
Chemical Properties
Molecular Formula: Memantine — C12H21N; Upadacitinib — C17H19F3N6O.
Molecular Weight: Memantine — 179.3080 g/mol; Upadacitinib — 380.3700 g/mol.
Type: Memantine — Small molecule; Upadacitinib — Small molecule.